Published in J Rheumatol on March 01, 2010
Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Arthritis Res Ther (2011) 1.55
Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent? Ann Rheum Dis (2012) 0.98
Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. Arthritis Res Ther (2016) 0.78
Contextual and time dependent pain in fibromyalgia: an explorative study. BMC Res Notes (2012) 0.76
Predictors of frequent oral analgesic use in rheumatoid arthritis. Pak J Med Sci (2014) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Measurement of patient outcome in arthritis. Arthritis Rheum (1980) 21.31
A critical appraisal of the quality of quality-of-life measurements. JAMA (1994) 9.10
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
Application of multi-attribute utility theory to measure social preferences for health states. Oper Res (1983) 2.92
Clinical measures in rheumatoid arthritis: which are most useful in assessing patients? J Rheumatol (1994) 2.37
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis (1992) 2.26
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl (1994) 2.23
The relative importance of pain and functional disability to patients with rheumatoid arthritis. J Rheumatol (1993) 1.67
Validity of the Center for Epidemiological Studies Depression Scale in arthritis populations. Arthritis Rheum (1989) 1.60
"Arthritis specific" global health analog scales assess "generic" health related quality-of-life in patients with rheumatoid arthritis. J Rheumatol (1997) 1.25
Feasibility of utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia. J Rheumatol (1994) 1.01
Correlates of patients' global assessment of arthritis impact. A 2-year study of 216 patients with RA. Scand J Rheumatol (1997) 1.01
A clinical trial to evaluate the measurement properties of 2 direct preference instruments administered with and without hypothetical marker states. Med Decis Making (2003) 0.93
A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux disease. Med Care (2004) 0.88
Marker states and a health state prompt provide modest improvements in the reliability and validity of the standard gamble and rating scale in prostate cancer patients. Qual Life Res (2007) 0.81
Do clinical marker states improve responsiveness and construct validity of the standard gamble and feeling thermometer: a randomized multi-center trial in patients with chronic respiratory disease. Qual Life Res (2006) 0.80
Critical review of clinical assessment techniques for rheumatoid arthritis trials: new developments. Scand J Rheumatol Suppl (1989) 0.79
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet (2011) 5.56
Patient participation in medical consultations: why some patients are more involved than others. Med Care (2005) 3.68
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet (2010) 3.58
Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum (2005) 2.76
Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components. Arthritis Rheum (2006) 2.75
The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH. BMC Musculoskelet Disord (2006) 2.67
The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum (2013) 2.40
Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA (2007) 2.17
Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheum (2013) 1.72
Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum (2007) 1.53
Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis (2006) 1.47
Suicidal ideation among adults with arthritis: prevalence and subgroups at highest risk. Data from the 2007-2008 National Health and Nutrition Examination Survey. Arthritis Care Res (Hoboken) (2011) 1.42
Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab (2003) 1.36
Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983-2007. Ann Rheum Dis (2009) 1.36
Ethnic and socioeconomic disparities in health among patients with rheumatic disease. Curr Opin Rheumatol (2005) 1.34
Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci U S A (2011) 1.33
Time perspective and socioeconomic status: a link to socioeconomic disparities in health? Soc Sci Med (2009) 1.27
Computer aided evaluation of ankylosing spondylitis using high-resolution CT. IEEE Trans Med Imaging (2008) 1.19
Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study. Arthritis Rheum (2012) 1.10
Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis. Arthritis Res Ther (2009) 1.08
Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5. J Rheumatol (2010) 1.05
Role of metastasectomy in the management of thyroid carcinoma: the NIH experience. J Surg Oncol (2003) 1.01
Socioeconomic and ethnic differences in disease burden and disparities in physical function in older adults. Am J Public Health (2010) 0.99
Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet (2013) 0.96
Sleep disturbances in adults with arthritis: prevalence, mediators, and subgroups at greatest risk. Data from the 2007 National Health Interview Survey. Arthritis Care Res (Hoboken) (2011) 0.96
Estimating rare disease prevalence from administrative hospitalization databases. Epidemiology (2005) 0.95
Sex disparities in self-reported physical functioning: true differences, reporting bias, or incomplete adjustment for confounding? J Am Geriatr Soc (2010) 0.95
Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States. Arthritis Care Res (Hoboken) (2014) 0.94
Economic considerations of the treatment of ankylosing spondylitis. Am J Med Sci (2012) 0.93
Psychological correlates of self-reported disease activity in ankylosing spondylitis. J Rheumatol (2010) 0.92
Quantitative measurement of syndesmophyte volume and height in ankylosing spondylitis using CT. Ann Rheum Dis (2013) 0.92
The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitis. Rheumatology (Oxford) (2011) 0.91
The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-associated death domain (TRADD). Ann Rheum Dis (2009) 0.90
Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus. Arthritis Rheum (2003) 0.88
Cervical vertebral squaring in patients without spondyloarthritis. J Rheumatol (2012) 0.88
Advances in the treatment of inflammatory arthritis. Best Pract Res Clin Rheumatol (2012) 0.87
A pilot study of yoga as self-care for arthritis in minority communities. Health Qual Life Outcomes (2013) 0.86
Improved precision of syndesmophyte measurement for the evaluation of ankylosing spondylitis using CT: a phantom and patient study. Phys Med Biol (2012) 0.85
Time perspective and smoking, obesity, and exercise in a community sample. Am J Health Behav (2013) 0.84
Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases. Arthritis Res Ther (2010) 0.83
Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients. Radiology (2010) 0.81
Interpreting studies of cardiovascular mortality in rheumatoid arthritis: the importance of timing. Arthritis Rheum (2008) 0.81
Validation of new biomarkers in systemic autoimmune diseases. Nat Rev Rheumatol (2011) 0.81
Prospects for disease modification in ankylosing spondylitis: do nonsteroidal antiinflammatory drugs do more than treat symptoms? Arthritis Rheum (2005) 0.80
Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus. Arthritis Rheum (2012) 0.80
Rheumatology care, patient expectations, and the limits of time. Arthritis Rheum (2004) 0.80
Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis? Arthritis Care Res (Hoboken) (2012) 0.80
Association of measured physical performance and demographic and health characteristics with self-reported physical function: implications for the interpretation of self-reported limitations. Health Qual Life Outcomes (2010) 0.80
Brief report: rheumatoid arthritis response criteria and patient-reported improvement in arthritis activity: is an American College of Rheumatology twenty percent response meaningful to patients? Arthritis Rheumatol (2014) 0.80
Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation. Arthritis Rheumatol (2014) 0.80
Time perspective and exercise, obesity, and smoking: moderation of associations by age. Am J Health Promot (2013) 0.79
Validation of English and Spanish-language versions of a screening questionnaire for rheumatoid arthritis in an underserved community. J Rheumatol (2008) 0.79
Measurement and treatment of radiographic progression in ankylosing spondylitis: lessons learned from observational studies and clinical trials. Curr Opin Rheumatol (2014) 0.78
Trends in hospitalizations for Pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the US: 1996-2007. Arthritis Rheum (2010) 0.78
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging. Clin Nucl Med (2003) 0.78
Medicare reimbursement and the use of biologic agents: incentives, access, the public good, and optimal care. Arthritis Care Res (Hoboken) (2010) 0.78
Syndesmophyte growth in ankylosing spondylitis. Curr Opin Rheumatol (2015) 0.77
High precision semi-automated vertebral height measurement using computed tomography: A phantom study. Conf Proc IEEE Eng Med Biol Soc (2012) 0.77
Ceiling effects and the Schober test. J Rheumatol (2003) 0.77
Estimating disease prevalence and incidence using administrative data: some assembly required. J Rheumatol (2013) 0.77
Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative? Arthritis Care Res (Hoboken) (2013) 0.77
Clinically important changes in short form 36 health survey scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness. Arthritis Care Res (Hoboken) (2014) 0.77
Rheumatoid arthritis: Guidelines for the management of RA: breadth versus depth. Nat Rev Rheumatol (2009) 0.77
Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol (2006) 0.76
17 and 23: prime numbers for ankylosing spondylitis? Lancet (2013) 0.76
Short-term perioperative all-cause mortality and cardiovascular events in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2013) 0.75
Physical therapy and surgery. Am J Med Sci (2012) 0.75
Measures of psychological distress in patients with arthritis: comment on the article by Fuller-Thomson and Shaked. Arthritis Care Res (Hoboken) (2010) 0.75
Linear measurement of polyps in CT colonography using level sets on 3D surfaces. Conf Proc IEEE Eng Med Biol Soc (2009) 0.75
Precision of syndesmophyte volume measurement for ankylosing spondylitis: a phantom study using high resolution CT. Conf Proc IEEE Eng Med Biol Soc (2009) 0.75
Sulfasalazine for the treatment of ankylosing spondylitis: relic or niche medication? Arthritis Rheum (2011) 0.75
High precision semiautomated computed tomography measurement of lumbar disk and vertebral heights. Med Phys (2013) 0.75
Autoimmune diseases: early diagnosis and new treatment strategies. Clin Chem (2012) 0.75